Stockscreener 앱 받기
44.23
0.07%
0.03
전일 마감가:
$44.20
열려 있는:
$44.4
하루 거래량:
29.91M
Relative Volume:
1.50
시가총액:
$65.74B
수익:
$20.62B
순이익/손실:
$3.56B
주가수익비율:
18.55
EPS:
2.3847
순현금흐름:
$3.48B
1주 성능:
-2.34%
1개월 성능:
-23.27%
6개월 성능:
-53.96%
1년 성능:
-57.71%
1일 변동 폭
$44.02
$45.22
1주일 범위
$43.89
$45.83
52주 변동 폭
$43.89
$109.50
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
44.23 | 65.70B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
94.12 | 162.41B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
332.71 | 121.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.98 | 103.07B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
90.78 | 51.66B | 6.30B | 1.07B | 1.09B | 1.8406 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-30 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific (NYSE:BSX) Gains Fresh Market Attention - Kalkine Media
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX) - Insider Monkey
Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating - marketscreener.com
BSX Maintains Buy Rating by Jefferies -- Price Target Lowered to $67.00 - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific (BSX) Faces 52.54% Decline Amid Weak Momentum Grades - GuruFocus
Jefferies Adjusts Price Target on Boston Scientific to $67 From $100, Maintains Buy Rating - marketscreener.com
Boston Scientific Corp (BSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX) - Insider Monkey
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own” - Insider Monkey
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance UK
Boston Scientific stock hits 52-week low at 44.41 USD By Investing.com - Investing.com Australia
Boston Scientific Spinal Cord Stimulator Lawsuit for SCS Injuries - robertkinglawfirm.com
Boston Scientific stock hits 52-week low at 44.41 USD - Investing.com UK
Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device - Insider Monkey
Boston Scientific Corp Recalls Orca Sterile Single-Use Air/Water and Suction Valves - marketscreener.com
Boston Sci-Mirus pact lifts med-tech dealmaking to record $4.5B in May - BioWorld News
Boston Scientific Corp (BSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Trueblood Wealth Management, LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp (BSX) Stock Down 4.2% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CAFC Affirms Denial of Preliminary Injunction for Boston Scientific in Spinal Ablation Patent Dispute Against Stryker - IPWatchdog.com
Stryker Fends Off Boston Scientific Bid to Block Ablation Device - Bloomberg Law News
Below Expected Outlook Pressured Boston Scientific (BSX) in Q1 - Yahoo Finance
Boston Scientific Corp. Stock (US10117L1017): Short interest jumps while analysts stay positive - AD HOC NEWS
Why Did ADBE, CHWY, BSX Slump To 52-Week Lows Last Week? - TradingView
Truist Reiterates Buy Rating for Boston Scientific (BSX) - Insider Monkey
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Yahoo Finance
Boston Scientific Stock Price Decline Analysis - Intellectia AI
Boston Scientific shares plunge 53% amid lowered growth forecasts and product challenges - Pluang
UniSuper Management Pty Ltd Has $72.53 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific - Yahoo Finance
Polen Capital Management LLC Sells 1,578,734 Shares of Boston Scientific Corporation $BSX - MarketBeat
Meiji Yasuda America Inc Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Nuveen LLC Lowers Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Great Lakes Advisors LLC Has $169.42 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Analyst recommendations: Adobe, Boston Scientific, Casey's General Stores, Kla Corporation, Zillow Group… - marketscreener.com
Aviva PLC Has $141.66 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Top Boston Scientific (BSX) Competitors 2026 - MarketBeat
Boston Scientific Corp (BSX) Reports Strong Success Rates From Catheter Study - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Scientific stock hits 52-week low at 47.16 USD - Investing.com India
BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock - Insider Monkey
FY2026 EPS Estimate for Boston Scientific Lowered by Analyst - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
0.70%
자본화:
|
볼륨(24시간):